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CC BY-NC-ND license (http://creativeAbstract The aim of this study was to compare the clinical outcomes of anti-incontinence
surgeries employing the transobturator sling and single-incision sling (SIS). Our hypothesis is
that the outcome of the SIS is not inferior to the obturator sling. This retrospective study re-
viewed the medical records of patients who underwent anti-incontinence surgery with the
transobturator sling or SIS from July 2005 to November 2014. Patients who underwent concom-
itant pelvic organ reconstruction with an artificial mesh were excluded. Assessments included
preoperative and postoperative urodynamic examinations, perioperative complications, and
postoperative urogenital symptoms. A total of 122 women were recruited according to the in-
clusion and exclusion criteria. Among them, 68 patients underwent transobturator sling proce-
dures while 54 patients underwent SIS procedures. The subjective failure rate of the
transobturator sling and SIS were 10.2% and 18.5%, respectively (p Z 0.292). The objective
failure rate, defined as a pad test showing more than 2 g of urine, was 10.2% for the transob-
turator sling and 12.9% for the SIS (p Z 0.777). SIS resulted in less blood loss, operative time,
length of hospital stay, and transient voiding dysfunction after the operation. No major compli-
cation occurred after either surgical intervention. In conclusion, SIS and transobturator slings
might have similar efficacy, safety, and effects on new-onset urogenital symptoms.
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Stress urinary incontinence (SUI) is the involuntary leakage
of urinary flow as abdominal pressure increases, and the
bladder neck opens. It is the most common type of urinary
incontinence in women and leads to deterioration in the
quality of life of those affected. The prevalence of SUI
ranges from 4% to 35% [1,2] and increasing numbers of pa-
tients are complaining about the problem. One possibility
for this increase is that people are living longer, and aging is
a risk factor for SUI [3].
Determining the optimal management of SUI is essential
due to its adverse effect on quality of life. The initial man-
agement of SUI includes conservative therapy such as pelvic
floor muscle training, electrical stimulation, biofeedback,
and pessary use. However, patients often consider these
treatments time-consuming and less effective.
The Burch colposuspension procedure was regarded as
the “gold standard” initially; nevertheless, with the
development of reproducible minimally invasive tech-
niques, anti-incontinence slings have become the com-
monest SUI treatment [4]. The first synthetic polypropylene
midurethral sling, known as tension-free vaginal tape
(TVT), was introduced by Ulmsten in 1996, and it had
satisfactory effects on SUI [5,6]. In an 11-year prospective
study, the subjective cure rate was 77% while the objective
cure rate was 90% [7]. In another prospective study lasting
17 years, the subjective cure rate was 90%, and the
objective cure rate was 87% [8]. In a previous study we
conducted, concomitant surgery with TVT had a satisfac-
tory objective cure rate of 84.9e86.8% [9].
To minimize tissue trauma and complications, the sling
was inserted towards the transobturator area and was
called transobturator sling. Such slings were known as TVT-
O (tension-free vaginal tape-obturator, Ethicon, NJ, USA)
and Monarc (American Medical Systems, Eden Prairie, MN,
USA). A systematic review and a prospective randomized
trial revealed that their efficacies were satisfactory to
patients compared with TVT [10,11].
The most recent surgical development for the treatment
of SUI is the single-incision sling (SIS), also known as the
MiniArc (American Medical Systems), which was developed
in 2007. The MiniArc needs only one incision in the vaginal
wall, and the sling is much shorter than previous mid-
urethral slings. Because the sling is only around 8 cm in
length, its insertion trajectory is shorter, so complications
such as bladder perforation, major vascular injury, and
postoperative pain in the groin region are avoided. A pro-
spective study reporting 1-year outcomes for the MiniArc
showed that 90.6% of the patients had a negative cough
stress test after the procedure [12]. Another two studies
showed equal efficacy of the transobturator sling and SIS
[13,14]. Nevertheless, a meta-analysis collecting data from
nine randomized, controlled trials showed inferior subjec-
tive and objective cure rates and higher reoperation rates
for SUI when SIS was compared with the standard mid-
urethral sling [15]. Because the efficacy of the SIS
compared with the transobturator sling is still under
debate, we compared the effectiveness of both procedures
for the treatment of SUI and its associated urogenital
symptoms.Methods
In this retrospective study, we compared the clinical out-
comes of two types of anti-incontinence slings, the trans-
obturator sling and the SIS. We enrolled patients who
underwent anti-incontinence surgery using the TVT-O,
Monarc, or MiniArc techniques and slings at a tertiary
referral urogynecological center in Kaohsiung, Taiwan from
July 2005 to November 2014. Data on the TVT-O procedure
was collected from May 2007 to November 2014. Data on
the Monarc sling procedure was collected from July 2005 to
July 2009, while MiniArc sling data was collected from
September 2010 to July 2014. All study candidates were
both clinically and urodynamically diagnosed with SUI. We
excluded patients who underwent concomitant pelvic organ
reconstruction surgery with an artificial mesh in order to
exclude other factors that could have impacted the uro-
dynamic studies and clinical outcomes. Baseline charac-
teristics, blood loss, operative time, length of hospital stay,
and preoperative and postoperative urodynamic studies
were assessed. Perioperative complications, failure, and
the effects on urogenital symptoms were also analyzed and
compared.
All of the surgeries were performed by two experienced
surgeons (KHH and FCC). Prophylactic antibiotics (intrave-
nous cefazolin 1 g) were administered 30 minutes before
surgery and every 8 hours for 2 days after surgery. All of the
procedures were performed in the lithotomy position under
general anesthesia, except when the patient’s condition
was unsuitable; then, the anesthesia was converted to
spinal anesthesia. The slings were inserted according to the
techniques described by the manufacturers. Intraoperative
cystoscopy was performed on each patient following sling
insertion to detect possible bladder injury. Thereafter,
vaginal packing with gauze for compression and Foley
catheter for urination were placed appropriately.
Usually, the vaginal gauze and Foley catheter were
removed the following day if the patient underwent SIS and
after 2 days for the group that underwent transobturator
sling insertion. Residual urine (RU) after self-voiding was
checked with ultrasound, and if the RU was more than
100 mL, we performed intermittent catheterization until
the RU was less than 100 mL. Once patients voided
smoothly, and the RU was less than 100 mL twice consec-
utively, the patients could be discharged. Postoperative
monitoring in the outpatient department was conducted at
1 week, 1 month, 3 months, 6 months, and 12 months after
the surgery, and then annually. Postoperative urodynamic
studies and the urinary pad test were completed 6 months
after the surgery.
We reviewed the charts and recorded the patients’
subjective complaints regarding new-onset and post-
operative urogenital symptoms and the times at which they
occurred. Such symptoms included urgency, urgency in-
continence, nocturia, urinary retention sensation, enuresis,
and dyspareunia. Because we intended to identify the de
novo symptoms, if the patients had complained of these
symptoms before the surgery, they were classified into the
unaffected group.
Collected data was analyzed using independent and
paired t-tests for parametric and nonparametric continuous
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ables. Additionally, we used the KaplaneMeier method to
determine if there were statistically different probabilities
of occurrence of an event at a certain point in time be-
tween two groups. A p value of less than 0.05 was consid-
ered statistically significant.
Results
A total of 122 patients met the study criteria. Among them,
68 patients underwent transobturator sling procedures,
including the Monarc (N Z 43) and TVT-O (N Z 25)Table 1 Baseline characteristics.
Variables Transobturator
sling (N Z 68)
Single-incision
sling (N Z 54)
p
Age (y) 54.3 (15.8) 58.2(9.7) 0.110
Parity 3.3 (0e8) 3.0 (0e6) 0.128
VD 2.7 (1.4) 2.8 (1.2) 0.532
CS 0.1 (0.4) 0.1 (0.5) 0.939
BMI (kg/m2) 26.8 (4.5) 25.7 (3.8) 0.190
DM 11 (16.1) 12 (22.2) 0.396
Prior surgery
for SUI
2 (2.9) 3 (5.5) 0.469
Prior
hysterectomy
11 (16.1) 6 (11.1) 0.446
Menopause 34 (50) 38 (70.4) 0.022*
HRT 5 (7.3) 1 (1.8) 0.163
Calculated with independent t test. Values are given as mean
(standard deviation) or number of patients (%).
BMIZ body mass index; CSZ cesarean section; DMZ diabetes
mellitus; HRT Z hormone replacement therapy; VD Z vaginal
delivery.
* p < 0.05 is considered statistically significant.
Table 2 Comparison of urodynamic study of transobturator and
Preoperative
Transobturator
sling (N Z 68)
Single-incision
sling (N Z 54)
Qmax (mL/s) 25.0 (10.0) 28.5(11.1)
Qavg (mL/s) 10.0 (4.6) 10.2 (5.3)
VV (mL) 363.7 (222.0) 348.4 (152.9)
RU (mL) 39.0 (42.6) 27.5 (20.1)
MaxCap (mL) 375.0 (108.8) 355.6 (74.1)
MUCP (cmH2O) 68.5 (29.8) 59.7 (27.0)
FL (mm) 34.1 (8.3) 25.7 (8.5) <
FD (mL) 164.3 (65.6) 150.2 (42.2)
Pad test (g) 39.6 (33.8) 40.6 (44.2)
Pad test > 2 g
Improvementa
Positive pad test
Calculated with independent t test and Chi-square test. Values are g
* p < 0.05 is considered statistically significant.
FD Z first desire to void; FL Z functional length; MaxCap Z m
Qavg Z average flow rate; Qmax Z maximal flow rate; RU Z residu
a Improvement means pad test as 0e2 g.procedures while 54 underwent SIS procedures including
the MiniArc (N Z 54). The overall mean postoperative
follow-up period was 20.8 months (range, 15e90 months).
Table 1 shows the demographic data of the transobturator
sling and SIS groups. There were no significant differences
between the two groups for age, parity, type of delivery,
body mass index, history of diabetes mellitus, incontinence
surgery, or hysterectomy. More women had reached
menopause in the SIS group than in the transobturator sling
group (70.4% vs. 50%; p Z 0.022).
The preoperative urodynamic parameters were similar in
the two groups (Table 2), except for the urethral functional
length, which was significantly less in the SIS group. The
postoperative urodynamic parameters (Table 2) were also
similar, except for maximal urethral closure pressure
(MUCP) and functional length, which were statistically
lower in the SIS group.
Comparing the preoperative and postoperative urody-
namic studies in the two groups (Table 3), we found that
both groups had remarkable improvements in the pad test
(from 39.6 g to 1.5 g of urine in the transobturator sling
group; from 40.6 g to 3.75 g of urine in the SIS group;
p < 0.001 for both). The MUCP decreased remarkably after
SIS insertion (p Z 0.017) but not in the transobturator
group. The other parameters did not differ significantly
between the groups.
In the transobturator sling group, two patients under-
went the surgery due to recurrence. One patient had un-
dergone TVT-O insertion 4 years earlier. After the anti-
incontinence surgery with transobturator sling this time,
she complained about recurrent SUI 4 months later,
although the pad test showed 0 g until the 48-month follow-
up visit. She then underwent extracorporeal magnetic
innervation. The other patient had undergone an unknown
type of sling insertion for urinary incontinence 6 years
earlier. She underwent the transobturator sling procedure
this time, and her pad test was negative and no recurrence
was found during follow-up.single-incision sling.
Postoperative
p Transobturator
sling (N Z 68)
Single-incision
sling (N Z 54)
p
0.065 24.0 (9.3) 26.2 (10.2) 0.226
0.881 10.1 (4.8) 9.8 (4.2) 0.734
0.654 312.1(147.3) 318.1 (160.8) 0.829
0.051 39.3 (72.2) 28.4 (44.9) 0.336
0.245 366.7 (99.1) 355.8 (85.8) 0.523
0.093 64.3 (26.0) 50.9 (22.3) 0.003*
0.001* 33.9 (22.1) 25.7 (7.4) 0.005*
0.152 169.1 (71.2) 151.7 (57.8) 0.149
0.893 1.5 (5.9) 3.7(16.4) 0.311
7 (10.2) 7 (12.9) 0.777
2 (2.9) 4 (7.4)
9 (13.2) 11 (20.3) 0.292
iven as mean (standard deviation) or number of patients (%).
aximal capacity; MUCP Z maximal urethral closure pressure;
al urine; VV Z voided volume.
Table 3 Comparison of preoperative and postoperative urodynamic study.
Transobturator sling (N Z 68) Single-incision sling (N Z 54)
Preoperative Postoperative p Preoperative Postoperative p
Qmax (mL/s) 25.0 (10.0) 24.0 (9.3) 0.543 28.5 (11.1) 26.2 (10.2) 0.201
Qavg (mL/s) 10.0 (4.6) 10.1 (4.8) 0.984 10.2 (5.3) 9.8 (4.2) 0.591
VV (mL) 363.7 (222.0) 312.1 (147.3) 0.083 348.4 (152.9) 318.1 (160.8) 0.307
RU (mL) 39.0 (42.6) 39.3 (72.2) 0.976 27.5 (20.1) 28.4 (44.9) 0.888
MaxCap (mL) 375.0 (108.8) 366.7 (99.1) 0.585 355.6 (74.1) 355.8 (85.8) 0.988
MUCP (cmH2O) 68.5 (29.8) 64.3 (26.0) 0.180 59.7 (27.0) 50.9 (22.3) 0.017*
FL (mm) 34.1 (8.3) 33.9 (22.1) 0.933 25.7 (8.5) 25.7 (7.4) 0.973
FD (mL) 164.3 (65.6) 169.1 (71.2) 0.695 150.2 (42.2) 151.7 (57.8) 0.886
Pad test (g) 39.6 (33.8) 1.5 (5.9) <0.001* 40.6 (44.2) 3.75 (16.4) <0.001*
Calculated with paired t test. Values are given as mean (standard deviation) or number of patients (%).
* p < 0.05 is considered statistically significant.
FD Z first desire to void; FL Z functional length; MaxCap Z maximal capacity; MUCP Z maximal urethral closure pressure;
Qavg Z average flow rate; Qmax Z maximal flow rate; RU Z residual urine; VV Z voided volume.
Table 5 Comparison of effect on urogenital symptoms
and failure of transobturator and single-incision sling.
Transobturator
sling (N Z 68)
Single-incision
sling (N Z 54)
p*
Sling exposure 1 (1.4) 0 (0) 1.000
Dyspareunia 2 (2.9) 0 (0) 0.503
De novo urgency 9 (13.2) 6 (11.1) 0.787
Urgency
incontinence
6 (8.8) 5 (9.2) 1.000
Urinary frequency 5 (7.3) 2 (3.7) 0.462
Urinary difficulty 4 (5.8) 1 (1.8) 0.381
Urinary retention 3 (4.4) 2 (3.7) 1.000
Urinary tract
infection
1 (1.4) 3 (5.5) 0.321
Nocturia 11 (16.1) 3 (5.5) 0.088
Enuresis 1 (1.4) 0 (0) 1.000
Subjective failure 7 (10.2) 10 (18.5) 0.292
Objective failure 7 (10.2) 7 (12.9) 0.777
Calculated with Fisher’s exact test. Values are given as mean
(standard deviation) or number of patients (%).
* p < 0.05 is considered statistically significant.
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second time due to recurrence. Two had undergone TVT
insertion, and the other had had the Monarc sling previ-
ously. After the SIS procedure, one had a positive 23-g pad
test 6 months later. However, she was satisfied with the
operation and did not have to use pad protection again.
Another patient had a positive 12-g pad test 34 months
after the current SIS procedure. The third patient returned
to the outpatient department 6 months after the current
SIS operation and at that time she was satisfied with the
intervention and the pad test was negative.
Regarding perioperative complications, SIS resulted in
less blood loss, operative time, length of hospital stay, and
need for intermittent catheterization after removal of the
Foley catheter (Table 4).
Table 5 compares the postoperative, new-onset uro-
genital symptoms. Most of the urogenital symptoms did not
differ between the two groups. No bladder or bowel
perforation occurred in either group.
The subjective failure rate of the transobturator sling
and SIS were 10.2% and 18.5%, respectively (p Z 0.292).
Objective failure, defined as a pad test of more than 2 g,
occurred in 10.2% and 12.9% of patients in the trans-
obturator sling and SIS groups (p Z 0.777; Table 5).Table 4 Comparison of blood loss, operative time, hos-
pital stay, and postoperative intermittent catheterization
program (ICP).
Transobturator
sling (N Z 68)
Single-incision
sling (N Z 54)
p
Blood loss (mL) 96.3 (88.4) 50.3 (46.6) <0.001*
Operative
time (min)
79.2 (44.1) 51.3 (20.6) <0.001*
Hospital
stay (d)
3.7 (1.4) 2.4 (0.8) <0.001*
ICP 15 (22.0) 4 (7.4) 0.027*
Calculated with independent t test and Fisher’s exact test.
Values are given as mean (standard deviation) or number of
patients (%).
* p < 0.05 is considered statistically significant.The KaplaneMeier analysis showed that the new-onset
urogenital symptoms did not differ statistically between
the two groups after correcting the tracing time, nor did
the subjective and objective failure rates (Figures 1 and 2).
Discussion
The outcomes of the transobturator sling and SIS pro-
cedures differ between studies. A prospective study
including 162 patients showed objective cure rates of 86.9%
in the transobturator sling group and 90.9% in the SIS group
[16]. A retrospective, dual-center, cohort study of the
transobturator sling and the SIS surgeries showed that 91%
of the patients in both populations had negative cough
stress tests at the 6-month follow-up and 89% and 85%,
respectively, maintained a negative cough stress test at the
1-year follow-up visit [13]. Another prospective,
Figure 1. Probability of subjective failure of transobturator
sling and single-incision sling. KaplaneMeier event-free sur-
vival of the transobturator sling and single-incision sling groups
during the study period: similar subjective (p Z 0.091) in the
two groups.
Figure 2. Probability of objective failure of transobturator
sling and single-incision sling. KaplaneMeier event-free sur-
vival of the transobturator sling and single-incision sling groups
during the study period: objective failure (p Z 0.620) in the
two groups.
Slings for stress urinary incontinence 371randomized controlled trial including 194 patients reported
statistically lower objective cure rates for the SIS group
(97.6% vs. 83.6%) [17]. In our study, the SIS group had pad
tests less than 2 g in 87.1% of patients at the 6-month
follow-up, and both subjective and objective satisfaction
were comparable to those of the transobturator sling.
Regardless of patients choosing the transobturator sling
or SIS, the outcomes did not differ. Nonetheless, we found
that the SIS was a more favorable procedure than the
transobturator sling in terms of blood loss (96.3 mL vs.
50.3 mL, p < 0.001), operative time (79.2 minutes vs.
51.3 minutes, p < 0.001), and length of hospital stay
(3.7 days vs. 2.4 days, p < 0.001), as reported previously
[18]. Additionally, another benefit of this procedure was
that the SIS group required less intermittent catheteriza-
tion for postoperative temporary urinary retention,
although the rate (7.4%) in our study was higher than in
previous studies (3.2%) [19]. The operative time was much
longer than in previous studies because the patients also
underwent concomitant conventional pelvic reconstruction
surgery or hysterectomy for benign disease in our study. No
major intraoperative complication occurred.
In our study, we found that the MUCP both declined after
anti-incontinence surgery. With the transobturator sling, it
declined from 68.5 cmH2O to 64.3 cmH2O while it declined
from 59.7 cmH2O to 50.9 cmH2O in the SIS group. These
alterations might be associated with periurethral destruc-
tion during dissection for sling insertion.
The preoperative functional urethral length was shorter
in the SIS than in the transobturator group (25.7 mm vs.
34.1 mm, p < 0.001) in our study. In reviewing previous
studies, the few studies we found suggested that a shorter
functional urethral length was not associated with an un-
favorable outcome [20].
There was only one (1.4%) patient in the transobturator
sling group that experienced sling exposure. The patient
recovered well after excision of the exposed sling and su-
turing of the disrupted vaginal wall. Our result was similar
to the previous studies which showed the rate of trans-
obturator sling exposure ranging from less than 1% to 3%
[21e23]. There was only a few available publications
illustrating the rate of exposure of SIS and most of the
studies analyzed the TVT-Secur which showed that the rate
was about 3% [24]. There was no sling exposure after SIS
insertion in our study and we used MiniArc mostly; there-
fore, this might be the benefit of utilizing this kind of sling
for anti-incontinence surgery.
The new-onset urogenital symptoms were similar in the
two interventional groups and this result was compatible
with a previous study [16].
Because the follow-up times differed between the
groups, we used the KaplaneMeier analysis to eliminate the
bias. The KaplaneMeier analysis showed that the new-onset
urogenital symptoms did not differ statistically between
the two groups after correcting the tracing time; nor did
the subjective and objective failure rates (Figures 1 and 2).
Similar to previous studies, we concluded that the SIS
procedure was at least as good as the transobturator sling
procedure [13,18]. Nonetheless, our results are limited by
the retrospective study design, relatively small sample size,
short follow-up duration, and lack of results of the
372 L.-Y. Wu et al.questionnaire. A well-designed, prospective randomized
controlled trial is needed to validate the results.
In conclusion, according to our results, SIS and trans-
obturator slings might have similar efficacy and effects on
new-onset urogenital symptoms. They also have similar
anti-incontinence results. The transobturator sling proce-
dure required more operative time, had greater intra-
operative blood loss, a longer hospital stay, and greater
transient urine retention. The postoperative complication
was very low in both procedures.
Acknowledgments
This study was approved by the Institutional Ethics Review
Board of Chang Gung Memorial Hospital (Institutional Re-
view Board Number 104-2549B).
References
[1] Luber KM. The definition, prevalence, and risk factors for
stress urinary incontinence. Rev Urol 2004;6:S3e9.
[2] Haylen BT, Ridder DD, Freeman RM, Swift SE, Berghmans B,
Lee J, et al. An International Urogynecological Association
(IUGA)/International Continence Society (ICS) joint report on
the terminology for female pelvic floor dysfunction. Int Uro-
gynecol J 2010;21:5e26.
[3] Rortveit G, Daltveit AK, Hannestad YS, Hunskarr S. Urinary
incontinence after vaginal delivery or cesarean section. N Engl
J Med 2003;348:900e7.
[4] Suskind AM, Kaufman SR, Dunn RL, Stoffel JT, Clemens JQ,
Hollenbeck BK. Population-based trends in ambulatory surgery
for urinary incontinence. Int Urogynecol J 2013;24:207e11.
[5] Ulmsten U, Henriksson L, Johnson P, Varhos G. An ambulatory
surgical procedure under local anesthesia for treatment of
female urinary incontinence. Int Urogynecol J 1996;7:81e5.
[6] Ulmsten U, Johnson P, Rezapour M. A three-year follow up of
tension free vaginal tape for surgical treatment of female
stress urinary incontinence. Br J Obstet Gynaecol 1999;106:
345e50.
[7] Nilsson CG, Palva K, Rezapour M, Falconer C. Eleven years
prospective follow-up of the tension-free vaginal tape pro-
cedure for treatment of stress urinary incontinence. Int Uro-
gynecol J 2008;19:1043e7.
[8] Nilsson CG, Palva KF, Aarnio RF, Morcos EF, Falconer C.
Seventeen years’ follow-up of the tension-free vaginal tape
procedure for female stress urinary incontinence. Int Urogy-
necol J 2013;24:1265e9.
[9] Huang KH, Kung FT, Liang HM, Huang LY, Chang SY. Concomi-
tant surgery with tension-free vaginal tape. Acta Obstet
Gynecol Scand 2003;82:948e53.
[10] Sung VW, Schleinitz MD, Rardin CR, Ward RM, Myers DL.
Comparison of retropubic vs transobturator approach to
midurethral slings: a systematic review and meta-analysis. Am
J Obstet Gynecol 2007;197:3e11.
[11] David-Montefiore E, Frobert JL, Grisard-Anaf M, Lienhart J,
Bonnet K, Poncelet C, et al. Peri-operative complications andpain after the suburethral sling procedure for urinary stress
incontinence: a French prospective randomized multicenter
study comparing the retropubic and transobturator routes.
Eur Urol 2006;49:133e8.
[12] Kennelly MJ, Moore R, Nguyen JN, Lukban JC, Siegel S. Pro-
spective evaluation of a single incision sling for stress urinary
incontinence. J Urol 2010;184:604e9.
[13] De Ridder D, Berkers J, Deprest J, Verguts J, Ost D, Hamid D,
et al. Single incision mini-sling versus a transobutaror sling: a
comparative study on MiniArc and Monarc slings. Int Urogy-
necol J 2010;21:773e8.
[14] Lee JK, Rosamilia A, Dwyer PL, Lim YN, Muller R. Randomized
trial of a single incision versus an outside-in transobturator
midurethral sling in women with stress urinary incontinence:
12 month results. Am J Obstet Gynecol 2015;213. 35.e1e9.
[15] Mostafa A, Lim CP, Hopper L, Madhuvrata P. Abdel-Fattah.
Single-incision mini-slings versus standard midurethral slings
in surgical management of female stress urinary incontinence:
A meta-analysis of effectiveness and complications. Eur Urol
2014;65:402e27.
[16] Neuman M, Sosnovski V, Kais M, Ophir E, Bornstein J. Trans-
obturator vs single-incision suburethral mini-slings for treat-
ment of female stress urinary incontinence: early
postoperative pain and 3-year follow-up. J Minim Invasive
Gynecol 2011;18:769e73.
[17] Hinoul P, Vervest HA, den Boon J, Venema PL, Lakeman MM,
Milani AL, et al. A randomized, controlled trial comparing an
innovative single incision sling with an established trans-
obturator sling to treat female stress urinary incontinence. J
Urol 2011;185:1356e62.
[18] Schellart RP, Oude Rengerink K, Van der Aa F, Lucot JP,
Kimpe B, de Ridder DJ, et al. A randomized comparison of a
single-incision midurethral sling and a transobturator mid-
urethral sling in women with stress urinary incontinence: re-
sults of 12-mo follow-up. Eur Urol 2014;66:1179e85.
[19] Kennelly MJ, Moore R, Nguyen JN, Lukban J, Siegel S. Miniarc
single-incision sling for treatment of stress urinary inconti-
nence: 2-year clinical outcomes. Int Urogynecol J 2012;23:
1285e91.
[20] Chen HY, Chiu TH, Ho M, Hung YC. Analysis of risk factors
associated with surgical failure of inside-out transobturator
vaginal tape for treating urodynamic stress incontinence. Int
Urogynecol J 2007;18:443e7.
[21] Waltregny D, Gaspar Y, Reul O, Hamida W, Bonnet P, de
Leval J. TVT-O for the treatment of female stress urinary in-
continence: results of a prospective study after a 3-year
minimum follow-up. Eur Urol 2008;53:401e8.
[22] Pushkar DY, Godunov BN, Gvozdev M, Kasyan GR. Complica-
tions of mid-urethral slings for treatment of stress urinary
incontinence. Int J Gynaecol Obstet 2011;113:54e7.
[23] Krofta L, Feyereisl J, Otcena´sek M, Velebil P, Kası´kova´ E,
Krcma´r M. TVT and TVT-O for surgical treatment of primary
stress urinary incontinence: Prospective randomized trial. Int
Urogynecol J 2010;21:141e8.
[24] Bianchi-Ferraro AM, Jarmy-DiBella ZI, de Aquino Castro R,
Bortolini MA, Sartori MG, Gira˜o MJ. Randomized controlled
trial comparing TVT-O and TVT-S for the treatment of stress
urinary incontinence: 2-year results. Int Urogynecol J 2014;25:
1343e8.
